Global OTC Pain Medicines Market Research Report 2022

Report Format: PDF   |   Report ID: 5515135   |   Published Date: August 2022   |   Pages:  103  

Choose License
Due to the COVID-19 pandemic, the global OTC Pain Medicines market size is estimated to be worth US$  million in 2021 and is forecast to a readjusted size of US$  million by 2028 with a CAGR of  % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe OTC Pain Medicines market is estimated at US$  million in 2022, while the United States and China are forecast to reach US$  million and US$  million by 2028, respectively. The proportion of the United States is  % in 2022, while Chinese percentage is  %, and it is predicted that China market share will reach  % in 2028, trailing a CAGR of  % through the analysis period. As for the Europe OTC Pain Medicines landscape, Germany is projected to reach US$  million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is  % and  % respectively for the next 6-year period.
Acetaminophen accounting for  % of the OTC Pain Medicines global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital Pharmacies segment is altered to an  % CAGR throughout this forecast period and will hold a share about  % in 2028.
The global major manufacturers of OTC Pain Medicines include GlaxoSmithKline, Pfizer, Novartis, Sanofi, Bayer, Mallinckrodt, Anqiu Lu'an, Granules India and Farmson, etc. In terms of revenue, the global 3 largest players have a  % market share of OTC Pain Medicines in 2021.
This report focuses on OTC Pain Medicines volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall OTC Pain Medicines market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global OTC Pain Medicines Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
    Acetaminophen
    Ibuprofen
    Aspirin
    Naproxen
    Others
Segment by Application
    Hospital Pharmacies
    Drug Stores
    E-Commerce
By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE
By Company
    GlaxoSmithKline
    Pfizer
    Novartis
    Sanofi
    Bayer
    Mallinckrodt
    Anqiu Lu'an
    Granules India
    Farmson
    Hebei Jiheng
    Zhejiang Kangle
    Sri Krishna Pharma
    Anhui BBCA Likang
    Seqens
    Xinhua Pharmaceutical
    IOLCP
    Granules Biocause
    Strides Shasun
1 OTC Pain Medicines Market Overview
    1.1 Product Overview and Scope of OTC Pain Medicines
    1.2 OTC Pain Medicines Segment by Type
        1.2.1 Global OTC Pain Medicines Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 Acetaminophen
        1.2.3 Ibuprofen
        1.2.4 Aspirin
        1.2.5 Naproxen
        1.2.6 Others
    1.3 OTC Pain Medicines Segment by Application
        1.3.1 Global OTC Pain Medicines Sales Comparison by Application: (2022-2028)
        1.3.2 Hospital Pharmacies
        1.3.3 Drug Stores
        1.3.4 E-Commerce
    1.4 Global OTC Pain Medicines Market Size Estimates and Forecasts
        1.4.1 Global OTC Pain Medicines Revenue 2017-2028
        1.4.2 Global OTC Pain Medicines Sales 2017-2028
        1.4.3 OTC Pain Medicines Market Size by Region: 2017 Versus 2021 Versus 2028
2 OTC Pain Medicines Market Competition by Manufacturers
    2.1 Global OTC Pain Medicines Sales Market Share by Manufacturers (2017-2022)
    2.2 Global OTC Pain Medicines Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global OTC Pain Medicines Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers OTC Pain Medicines Manufacturing Sites, Area Served, Product Type
    2.5 OTC Pain Medicines Market Competitive Situation and Trends
        2.5.1 OTC Pain Medicines Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest OTC Pain Medicines Players Market Share by Revenue
        2.5.3 Global OTC Pain Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 OTC Pain Medicines Retrospective Market Scenario by Region
    3.1 Global OTC Pain Medicines Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global OTC Pain Medicines Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America OTC Pain Medicines Market Facts & Figures by Country
        3.3.1 North America OTC Pain Medicines Sales by Country
        3.3.2 North America OTC Pain Medicines Revenue by Country
        3.3.3 United States
        3.3.4 Canada
    3.4 Europe OTC Pain Medicines Market Facts & Figures by Country
        3.4.1 Europe OTC Pain Medicines Sales by Country
        3.4.2 Europe OTC Pain Medicines Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific OTC Pain Medicines Market Facts & Figures by Region
        3.5.1 Asia Pacific OTC Pain Medicines Sales by Region
        3.5.2 Asia Pacific OTC Pain Medicines Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 China Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
    3.6 Latin America OTC Pain Medicines Market Facts & Figures by Country
        3.6.1 Latin America OTC Pain Medicines Sales by Country
        3.6.2 Latin America OTC Pain Medicines Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa OTC Pain Medicines Market Facts & Figures by Country
        3.7.1 Middle East and Africa OTC Pain Medicines Sales by Country
        3.7.2 Middle East and Africa OTC Pain Medicines Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global OTC Pain Medicines Historic Market Analysis by Type
    4.1 Global OTC Pain Medicines Sales Market Share by Type (2017-2022)
    4.2 Global OTC Pain Medicines Revenue Market Share by Type (2017-2022)
    4.3 Global OTC Pain Medicines Price by Type (2017-2022)
5 Global OTC Pain Medicines Historic Market Analysis by Application
    5.1 Global OTC Pain Medicines Sales Market Share by Application (2017-2022)
    5.2 Global OTC Pain Medicines Revenue Market Share by Application (2017-2022)
    5.3 Global OTC Pain Medicines Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 GlaxoSmithKline
        6.1.1 GlaxoSmithKline Corporation Information
        6.1.2 GlaxoSmithKline Description and Business Overview
        6.1.3 GlaxoSmithKline OTC Pain Medicines Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 GlaxoSmithKline OTC Pain Medicines Product Portfolio
        6.1.5 GlaxoSmithKline Recent Developments/Updates
    6.2 Pfizer
        6.2.1 Pfizer Corporation Information
        6.2.2 Pfizer Description and Business Overview
        6.2.3 Pfizer OTC Pain Medicines Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 Pfizer OTC Pain Medicines Product Portfolio
        6.2.5 Pfizer Recent Developments/Updates
    6.3 Novartis
        6.3.1 Novartis Corporation Information
        6.3.2 Novartis Description and Business Overview
        6.3.3 Novartis OTC Pain Medicines Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 Novartis OTC Pain Medicines Product Portfolio
        6.3.5 Novartis Recent Developments/Updates
    6.4 Sanofi
        6.4.1 Sanofi Corporation Information
        6.4.2 Sanofi Description and Business Overview
        6.4.3 Sanofi OTC Pain Medicines Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Sanofi OTC Pain Medicines Product Portfolio
        6.4.5 Sanofi Recent Developments/Updates
    6.5 Bayer
        6.5.1 Bayer Corporation Information
        6.5.2 Bayer Description and Business Overview
        6.5.3 Bayer OTC Pain Medicines Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 Bayer OTC Pain Medicines Product Portfolio
        6.5.5 Bayer Recent Developments/Updates
    6.6 Mallinckrodt
        6.6.1 Mallinckrodt Corporation Information
        6.6.2 Mallinckrodt Description and Business Overview
        6.6.3 Mallinckrodt OTC Pain Medicines Sales, Revenue and Gross Margin (2017-2022)
        6.6.4 Mallinckrodt OTC Pain Medicines Product Portfolio
        6.6.5 Mallinckrodt Recent Developments/Updates
    6.7 Anqiu Lu'an
        6.6.1 Anqiu Lu'an Corporation Information
        6.6.2 Anqiu Lu'an Description and Business Overview
        6.6.3 Anqiu Lu'an OTC Pain Medicines Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Anqiu Lu'an OTC Pain Medicines Product Portfolio
        6.7.5 Anqiu Lu'an Recent Developments/Updates
    6.8 Granules India
        6.8.1 Granules India Corporation Information
        6.8.2 Granules India Description and Business Overview
        6.8.3 Granules India OTC Pain Medicines Sales, Revenue and Gross Margin (2017-2022)
        6.8.4 Granules India OTC Pain Medicines Product Portfolio
        6.8.5 Granules India Recent Developments/Updates
    6.9 Farmson
        6.9.1 Farmson Corporation Information
        6.9.2 Farmson Description and Business Overview
        6.9.3 Farmson OTC Pain Medicines Sales, Revenue and Gross Margin (2017-2022)
        6.9.4 Farmson OTC Pain Medicines Product Portfolio
        6.9.5 Farmson Recent Developments/Updates
    6.10 Hebei Jiheng
        6.10.1 Hebei Jiheng Corporation Information
        6.10.2 Hebei Jiheng Description and Business Overview
        6.10.3 Hebei Jiheng OTC Pain Medicines Sales, Revenue and Gross Margin (2017-2022)
        6.10.4 Hebei Jiheng OTC Pain Medicines Product Portfolio
        6.10.5 Hebei Jiheng Recent Developments/Updates
    6.11 Zhejiang Kangle
        6.11.1 Zhejiang Kangle Corporation Information
        6.11.2 Zhejiang Kangle OTC Pain Medicines Description and Business Overview
        6.11.3 Zhejiang Kangle OTC Pain Medicines Sales, Revenue and Gross Margin (2017-2022)
        6.11.4 Zhejiang Kangle OTC Pain Medicines Product Portfolio
        6.11.5 Zhejiang Kangle Recent Developments/Updates
    6.12 Sri Krishna Pharma
        6.12.1 Sri Krishna Pharma Corporation Information
        6.12.2 Sri Krishna Pharma OTC Pain Medicines Description and Business Overview
        6.12.3 Sri Krishna Pharma OTC Pain Medicines Sales, Revenue and Gross Margin (2017-2022)
        6.12.4 Sri Krishna Pharma OTC Pain Medicines Product Portfolio
        6.12.5 Sri Krishna Pharma Recent Developments/Updates
    6.13 Anhui BBCA Likang
        6.13.1 Anhui BBCA Likang Corporation Information
        6.13.2 Anhui BBCA Likang OTC Pain Medicines Description and Business Overview
        6.13.3 Anhui BBCA Likang OTC Pain Medicines Sales, Revenue and Gross Margin (2017-2022)
        6.13.4 Anhui BBCA Likang OTC Pain Medicines Product Portfolio
        6.13.5 Anhui BBCA Likang Recent Developments/Updates
    6.14 Seqens
        6.14.1 Seqens Corporation Information
        6.14.2 Seqens OTC Pain Medicines Description and Business Overview
        6.14.3 Seqens OTC Pain Medicines Sales, Revenue and Gross Margin (2017-2022)
        6.14.4 Seqens OTC Pain Medicines Product Portfolio
        6.14.5 Seqens Recent Developments/Updates
    6.15 Xinhua Pharmaceutical
        6.15.1 Xinhua Pharmaceutical Corporation Information
        6.15.2 Xinhua Pharmaceutical OTC Pain Medicines Description and Business Overview
        6.15.3 Xinhua Pharmaceutical OTC Pain Medicines Sales, Revenue and Gross Margin (2017-2022)
        6.15.4 Xinhua Pharmaceutical OTC Pain Medicines Product Portfolio
        6.15.5 Xinhua Pharmaceutical Recent Developments/Updates
    6.16 IOLCP
        6.16.1 IOLCP Corporation Information
        6.16.2 IOLCP OTC Pain Medicines Description and Business Overview
        6.16.3 IOLCP OTC Pain Medicines Sales, Revenue and Gross Margin (2017-2022)
        6.16.4 IOLCP OTC Pain Medicines Product Portfolio
        6.16.5 IOLCP Recent Developments/Updates
    6.17 Granules Biocause
        6.17.1 Granules Biocause Corporation Information
        6.17.2 Granules Biocause OTC Pain Medicines Description and Business Overview
        6.17.3 Granules Biocause OTC Pain Medicines Sales, Revenue and Gross Margin (2017-2022)
        6.17.4 Granules Biocause OTC Pain Medicines Product Portfolio
        6.17.5 Granules Biocause Recent Developments/Updates
    6.18 Strides Shasun
        6.18.1 Strides Shasun Corporation Information
        6.18.2 Strides Shasun OTC Pain Medicines Description and Business Overview
        6.18.3 Strides Shasun OTC Pain Medicines Sales, Revenue and Gross Margin (2017-2022)
        6.18.4 Strides Shasun OTC Pain Medicines Product Portfolio
        6.18.5 Strides Shasun Recent Developments/Updates
7 OTC Pain Medicines Manufacturing Cost Analysis
    7.1 OTC Pain Medicines Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of OTC Pain Medicines
    7.4 OTC Pain Medicines Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 OTC Pain Medicines Distributors List
    8.3 OTC Pain Medicines Customers
9 OTC Pain Medicines Market Dynamics
    9.1 OTC Pain Medicines Industry Trends
    9.2 OTC Pain Medicines Market Drivers
    9.3 OTC Pain Medicines Market Challenges
    9.4 OTC Pain Medicines Market Restraints
10 Global Market Forecast
    10.1 OTC Pain Medicines Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of OTC Pain Medicines by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of OTC Pain Medicines by Type (2023-2028)
    10.2 OTC Pain Medicines Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of OTC Pain Medicines by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of OTC Pain Medicines by Application (2023-2028)
    10.3 OTC Pain Medicines Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of OTC Pain Medicines by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of OTC Pain Medicines by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables Table 1. Global OTC Pain Medicines Sales Growth Rate Comparison by Type (2022-2028) & (Kiloton) & (US$ Million) Table 2. Global OTC Pain Medicines Sales Growth Rate Comparison by Application (2022-2028) & (Kiloton) & (US$ Million) Table 3. Global OTC Pain Medicines Market Size by Region (US$ Million) (2017 VS 2021 VS 2028) Table 4. Global OTC Pain Medicines Market Competitive Situation by Manufacturers in 2021 Table 5. Global OTC Pain Medicines Sales (Kiloton) of Key Manufacturers (2017-2022) Table 6. Global OTC Pain Medicines Sales Market Share by Manufacturers (2017-2022) Table 7. Global OTC Pain Medicines Revenue (US$ Million) by Manufacturers (2017-2022) Table 8. Global OTC Pain Medicines Revenue Share by Manufacturers (2017-2022) Table 9. Global Market OTC Pain Medicines Average Price (US$/Ton) of Key Manufacturers (2017-2022) Table 10. Manufacturers OTC Pain Medicines Manufacturing Sites and Area Served Table 11. Manufacturers OTC Pain Medicines Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global OTC Pain Medicines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in OTC Pain Medicines as of 2021) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global OTC Pain Medicines Sales by Region (2017-2022) & (Kiloton) Table 16. Global OTC Pain Medicines Sales Market Share by Region (2017-2022) Table 17. Global OTC Pain Medicines Revenue by Region (2017-2022) & (US$ Million) Table 18. Global OTC Pain Medicines Revenue Market Share by Region (2017-2022) Table 19. North America OTC Pain Medicines Sales by Country (2017-2022) & (Kiloton) Table 20. North America OTC Pain Medicines Sales Market Share by Country (2017-2022) Table 21. North America OTC Pain Medicines Revenue by Country (2017-2022) & (US$ Million) Table 22. North America OTC Pain Medicines Revenue Market Share by Country (2017-2022) Table 23. Europe OTC Pain Medicines Sales by Country (2017-2022) & (Kiloton) Table 24. Europe OTC Pain Medicines Sales Market Share by Country (2017-2022) Table 25. Europe OTC Pain Medicines Revenue by Country (2017-2022) & (US$ Million) Table 26. Europe OTC Pain Medicines Revenue Market Share by Country (2017-2022) Table 27. Asia Pacific OTC Pain Medicines Sales by Region (2017-2022) & (Kiloton) Table 28. Asia Pacific OTC Pain Medicines Sales Market Share by Region (2017-2022) Table 29. Asia Pacific OTC Pain Medicines Revenue by Region (2017-2022) & (US$ Million) Table 30. Asia Pacific OTC Pain Medicines Revenue Market Share by Region (2017-2022) Table 31. Latin America OTC Pain Medicines Sales by Country (2017-2022) & (Kiloton) Table 32. Latin America OTC Pain Medicines Sales Market Share by Country (2017-2022) Table 33. Latin America OTC Pain Medicines Revenue by Country (2017-2022) & (US$ Million) Table 34. Latin America OTC Pain Medicines Revenue Market Share by Country (2017-2022) Table 35. Middle East and Africa OTC Pain Medicines Sales by Country (2017-2022) & (Kiloton) Table 36. Middle East and Africa OTC Pain Medicines Sales Market Share by Country (2017-2022) Table 37. Middle East and Africa OTC Pain Medicines Revenue by Country (2017-2022) & (US$ Million) Table 38. Middle East and Africa OTC Pain Medicines Revenue Market Share by Country (2017-2022) Table 39. Global OTC Pain Medicines Sales by Type (2017-2022) & (Kiloton) Table 40. Global OTC Pain Medicines Sales Market Share by Type (2017-2022) Table 41. Global OTC Pain Medicines Revenue by Type (2017-2022) & (US$ Million) Table 42. Global OTC Pain Medicines Revenue Share by Type (2017-2022) Table 43. Global OTC Pain Medicines Price by Type (2017-2022) & (US$/Ton) Table 44. Global OTC Pain Medicines Sales (Kiloton) by Application (2017-2022) Table 45. Global OTC Pain Medicines Sales Market Share by Application (2017-2022) Table 46. Global OTC Pain Medicines Revenue by Application (2017-2022) & (US$ Million) Table 47. Global OTC Pain Medicines Revenue Share by Application (2017-2022) Table 48. Global OTC Pain Medicines Price by Application (2017-2022) & (US$/Ton) Table 49. GlaxoSmithKline Corporation Information Table 50. GlaxoSmithKline Description and Business Overview Table 51. GlaxoSmithKline OTC Pain Medicines Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 52. GlaxoSmithKline OTC Pain Medicines Product Table 53. GlaxoSmithKline Recent Developments/Updates Table 54. Pfizer Corporation Information Table 55. Pfizer Description and Business Overview Table 56. Pfizer OTC Pain Medicines Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 57. Pfizer OTC Pain Medicines Product Table 58. Pfizer Recent Developments/Updates Table 59. Novartis Corporation Information Table 60. Novartis Description and Business Overview Table 61. Novartis OTC Pain Medicines Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 62. Novartis OTC Pain Medicines Product Table 63. Novartis Recent Developments/Updates Table 64. Sanofi Corporation Information Table 65. Sanofi Description and Business Overview Table 66. Sanofi OTC Pain Medicines Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 67. Sanofi OTC Pain Medicines Product Table 68. Sanofi Recent Developments/Updates Table 69. Bayer Corporation Information Table 70. Bayer Description and Business Overview Table 71. Bayer OTC Pain Medicines Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 72. Bayer OTC Pain Medicines Product Table 73. Bayer Recent Developments/Updates Table 74. Mallinckrodt Corporation Information Table 75. Mallinckrodt Description and Business Overview Table 76. Mallinckrodt OTC Pain Medicines Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 77. Mallinckrodt OTC Pain Medicines Product Table 78. Mallinckrodt Recent Developments/Updates Table 79. Anqiu Lu'an Corporation Information Table 80. Anqiu Lu'an Description and Business Overview Table 81. Anqiu Lu'an OTC Pain Medicines Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 82. Anqiu Lu'an OTC Pain Medicines Product Table 83. Anqiu Lu'an Recent Developments/Updates Table 84. Granules India Corporation Information Table 85. Granules India Description and Business Overview Table 86. Granules India OTC Pain Medicines Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 87. Granules India OTC Pain Medicines Product Table 88. Granules India Recent Developments/Updates Table 89. Farmson Corporation Information Table 90. Farmson Description and Business Overview Table 91. Farmson OTC Pain Medicines Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 92. Farmson OTC Pain Medicines Product Table 93. Farmson Recent Developments/Updates Table 94. Hebei Jiheng Corporation Information Table 95. Hebei Jiheng Description and Business Overview Table 96. Hebei Jiheng OTC Pain Medicines Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 97. Hebei Jiheng OTC Pain Medicines Product Table 98. Hebei Jiheng Recent Developments/Updates Table 99. Zhejiang Kangle Corporation Information Table 100. Zhejiang Kangle Description and Business Overview Table 101. Zhejiang Kangle OTC Pain Medicines Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 102. Zhejiang Kangle OTC Pain Medicines Product Table 103. Zhejiang Kangle Recent Developments/Updates Table 104. Sri Krishna Pharma Corporation Information Table 105. Sri Krishna Pharma Description and Business Overview Table 106. Sri Krishna Pharma OTC Pain Medicines Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 107. Sri Krishna Pharma OTC Pain Medicines Product Table 108. Sri Krishna Pharma Recent Developments/Updates Table 109. Anhui BBCA Likang Corporation Information Table 110. Anhui BBCA Likang Description and Business Overview Table 111. Anhui BBCA Likang OTC Pain Medicines Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 112. Anhui BBCA Likang OTC Pain Medicines Product Table 113. Anhui BBCA Likang Recent Developments/Updates Table 114. Seqens Corporation Information Table 115. Seqens Description and Business Overview Table 116. Seqens OTC Pain Medicines Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 117. Seqens OTC Pain Medicines Product Table 118. Seqens Recent Developments/Updates Table 119. Xinhua Pharmaceutical Corporation Information Table 120. Xinhua Pharmaceutical Description and Business Overview Table 121. Xinhua Pharmaceutical OTC Pain Medicines Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 122. Xinhua Pharmaceutical OTC Pain Medicines Product Table 123. Xinhua Pharmaceutical Recent Developments/Updates Table 124. IOLCP Corporation Information Table 125. IOLCP Description and Business Overview Table 126. IOLCP OTC Pain Medicines Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 127. IOLCP OTC Pain Medicines Product Table 128. IOLCP Recent Developments/Updates Table 129. Granules Biocause Corporation Information Table 130. Granules Biocause Description and Business Overview Table 131. Granules Biocause OTC Pain Medicines Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 132. Granules Biocause OTC Pain Medicines Product Table 133. Granules Biocause Recent Developments/Updates Table 134. Strides Shasun Corporation Information Table 135. Strides Shasun Description and Business Overview Table 136. Strides Shasun OTC Pain Medicines Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 137. Strides Shasun OTC Pain Medicines Product Table 138. Strides Shasun Recent Developments/Updates Table 139. Production Base and Market Concentration Rate of Raw Material Table 140. Key Suppliers of Raw Materials Table 141. OTC Pain Medicines Distributors List Table 142. OTC Pain Medicines Customers List Table 143. OTC Pain Medicines Market Trends Table 144. OTC Pain Medicines Market Drivers Table 145. OTC Pain Medicines Market Challenges Table 146. OTC Pain Medicines Market Restraints Table 147. Global OTC Pain Medicines Sales Forecast by Type (2023-2028) & (Kiloton) Table 148. Global OTC Pain Medicines Sales Market Share Forecast by Type (2023-2028) Table 149. Global OTC Pain Medicines Revenue Forecast by Type (2023-2028) & (US$ Million) Table 150. Global OTC Pain Medicines Revenue Market Share Forecast by Type (2023-2028) Table 151. Global OTC Pain Medicines Sales Forecast by Application (2023-2028) & (Kiloton) Table 152. Global OTC Pain Medicines Sales Market Share Forecast by Application (2023-2028) Table 153. Global OTC Pain Medicines Revenue Forecast by Application (2023-2028) & (US$ Million) Table 154. Global OTC Pain Medicines Revenue Market Share Forecast by Application (2023-2028) Table 155. Global OTC Pain Medicines Sales Forecast by Region (2023-2028) & (Kiloton) Table 156. Global OTC Pain Medicines Sales Market Share Forecast by Region (2023-2028) Table 157. Global OTC Pain Medicines Revenue Forecast by Region (2023-2028) & (US$ Million) Table 158. Global OTC Pain Medicines Revenue Market Share Forecast by Region (2023-2028) Table 159. Research Programs/Design for This Report Table 160. Key Data Information from Secondary Sources Table 161. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of OTC Pain Medicines Figure 2. Global OTC Pain Medicines Market Share by Type in 2021 & 2028 Figure 3. Acetaminophen Product Picture Figure 4. Ibuprofen Product Picture Figure 5. Aspirin Product Picture Figure 6. Naproxen Product Picture Figure 7. Others Product Picture Figure 8. Global OTC Pain Medicines Market Share by Application in 2021 & 2028 Figure 9. Hospital Pharmacies Figure 10. Drug Stores Figure 11. E-Commerce Figure 12. Global OTC Pain Medicines Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 13. Global OTC Pain Medicines Market Size (2017-2028) & (US$ Million) Figure 14. Global OTC Pain Medicines Sales (2017-2028) & (Kiloton) Figure 15. OTC Pain Medicines Sales Share by Manufacturers in 2021 Figure 16. Global OTC Pain Medicines Revenue Share by Manufacturers in 2021 Figure 17. The Global 5 and 10 Largest OTC Pain Medicines Players: Market Share by Revenue in 2021 Figure 18. OTC Pain Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 19. Global OTC Pain Medicines Sales Market Share by Region (2017-2022) Figure 20. Global OTC Pain Medicines Sales Market Share by Region in 2021 Figure 21. Global OTC Pain Medicines Revenue Market Share by Region (2017-2022) Figure 22. Global OTC Pain Medicines Revenue Market Share by Region in 2021 Figure 23. United States OTC Pain Medicines Revenue Growth Rate (2017-2022) & (US$ Million) Figure 24. Canada OTC Pain Medicines Revenue Growth Rate (2017-2022) & (US$ Million) Figure 25. Germany OTC Pain Medicines Revenue Growth Rate (2017-2022) & (US$ Million) Figure 26. France OTC Pain Medicines Revenue Growth Rate (2017-2022) & (US$ Million) Figure 27. U.K. OTC Pain Medicines Revenue Growth Rate (2017-2022) & (US$ Million) Figure 28. Italy OTC Pain Medicines Revenue Growth Rate (2017-2022) & (US$ Million) Figure 29. Russia OTC Pain Medicines Revenue Growth Rate (2017-2022) & (US$ Million) Figure 30. China OTC Pain Medicines Revenue Growth Rate (2017-2022) & (US$ Million) Figure 31. Japan OTC Pain Medicines Revenue Growth Rate (2017-2022) & (US$ Million) Figure 32. South Korea OTC Pain Medicines Revenue Growth Rate (2017-2022) & (US$ Million) Figure 33. India OTC Pain Medicines Revenue Growth Rate (2017-2022) & (US$ Million) Figure 34. Australia OTC Pain Medicines Revenue Growth Rate (2017-2022) & (US$ Million) Figure 35. China Taiwan OTC Pain Medicines Revenue Growth Rate (2017-2022) & (US$ Million) Figure 36. Indonesia OTC Pain Medicines Revenue Growth Rate (2017-2022) & (US$ Million) Figure 37. Thailand OTC Pain Medicines Revenue Growth Rate (2017-2022) & (US$ Million) Figure 38. Malaysia OTC Pain Medicines Revenue Growth Rate (2017-2022) & (US$ Million) Figure 39. Mexico OTC Pain Medicines Revenue Growth Rate (2017-2022) & (US$ Million) Figure 40. Brazil OTC Pain Medicines Revenue Growth Rate (2017-2022) & (US$ Million) Figure 41. Argentina OTC Pain Medicines Revenue Growth Rate (2017-2022) & (US$ Million) Figure 42. Turkey OTC Pain Medicines Revenue Growth Rate (2017-2022) & (US$ Million) Figure 43. Saudi Arabia OTC Pain Medicines Revenue Growth Rate (2017-2022) & (US$ Million) Figure 44. UAE OTC Pain Medicines Revenue Growth Rate (2017-2022) & (US$ Million) Figure 45. Sales Market Share of OTC Pain Medicines by Type (2017-2022) Figure 46. Manufacturing Cost Structure of OTC Pain Medicines Figure 47. Manufacturing Process Analysis of OTC Pain Medicines Figure 48. OTC Pain Medicines Industrial Chain Analysis Figure 49. Channels of Distribution Figure 50. Distributors Profiles Figure 51. Bottom-up and Top-down Approaches for This Report Figure 52. Data Triangulation Figure 53. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us